Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis

Overview

Journal J Med Internet Res

Publisher JMIR Publications

Date 2025 Jan 24

PMID 39854703

Authors

Emma Bodner

Lena Roth

Kathleen Wiencke

Christian Bischoff

Peter Eh Schwarz

Affiliations

Soon will be listed here.

Abstract

Background: Digital technologies for type 2 diabetes mellitus (T2DM) care hold great potential to improve patients' health in the long term. Only a subset of telemedicine offerings are digital interventions that meet the criteria for prescribable digitale Gesundheitsanwendung (digital health apps; DiGAs) in Germany. Digital treatments further provide vast amounts of patient data that are important to generate evidence.

Objective: This systematic review aims to analyze the efficacy of multimodal digital therapies that mainly meet the DiGA criteria for patients with T2DM and to elicit the potential of such therapies. This includes evidence from randomized controlled trials (RCTs) as well as from real-world data. The outcome of interest was a reduction in glycated hemoglobin (hemoglobin A [HbA]; long-term blood glucose measurements).

Methods: A systematic literature search was conducted in the literature bases PubMed, LIVIVO, and Cochrane, based on the predefined PICO (Population; Intervention; Control; Outcome) scheme. Identified studies were assessed for risk of bias, pragmatism, and overall quality of evidence. Meta-analyses were conducted for between group differences using RCTs only, and for within-group differences using RCTs and non-RCTs, to examine the effect of the interventions on HbA.

Results: In total, 795 records were identified, of which 24 were eligible for this systematic review and 23 studies were eligible for the meta-analysis. The results of the meta-analyses showed significant and clinically relevant reductions in HbA in patients with T2DM. Regarding the between-group difference for HbA reduction, the pooled effect of the RCTs showed a reduction of -0.36% (95% CI -0.59% to -0.14%; P<.001), favoring app-based interventions. The average mean within-group reduction in HbA was -0.79 (95% CI -1.02 to -0.55), with no significant difference between RCTs (-0.69, 95% CI -1.13 to -0.24) and non-RCTs (-0.87, 95% CI -1.16 to -0.57; P<.01, differences between RCTs and RCTs P=.44). A pragmatism rating showed that both study types were on average (very) pragmatic, that is, close to usual care. However, the overall quality of evidence was low to very low.

Conclusions: This systematic review shows that digital therapies that mainly meet the DiGA criteria can effectively improve HbA in patients with T2DM. The integration of digital health care into usual care holds great potential and should be considered as a complementary option to usual care in the future.

Trial Registration: PROSPERO CRD42023440203; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=440203.

References

Lim S, Tay M, Ong K, Johal J, Yap Q, Chan Y . Association Between Mobile Health App Engagement and Weight Loss and Glycemic Control in Adults With Type 2 Diabetes and Prediabetes (D'LITE Study): Prospective Cohort Study. JMIR Diabetes. 2022; 7(3):e35039. PMC: 9568822. DOI: 10.2196/35039. View

ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D . 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2022; 46(Suppl 1):S111-S127. PMC: 9810474. DOI: 10.2337/dc23-S007. View

Majithia A, Kusiak C, Lee A, Colangelo F, Romanelli R, Robertson S . Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial. J Med Internet Res. 2020; 22(8):e21778. PMC: 7486672. DOI: 10.2196/21778. View

Lee E, Cha S, Yun J, Lim S, Lee J, Ahn Y . Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial. J Med Internet Res. 2022; 24(7):e37430. PMC: 9496112. DOI: 10.2196/37430. View

ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D . 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2022; 46(Suppl 1):S19-S40. PMC: 9810477. DOI: 10.2337/dc23-S002. View

Higgins J, Thompson S, Spiegelhalter D . A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009; 172(1):137-159. PMC: 2667312. DOI: 10.1111/j.1467-985X.2008.00552.x. View

Waki K, Fujita H, Uchimura Y, Omae K, Aramaki E, Kato S . DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients. J Diabetes Sci Technol. 2014; 8(2):209-215. PMC: 4455411. DOI: 10.1177/1932296814526495. View

Teli M, Thato R, Rias Y . Predicting Factors of Health-Related Quality of Life Among Adults With Type 2 Diabetes: A Systematic Review. SAGE Open Nurs. 2023; 9:23779608231185921. PMC: 10336768. DOI: 10.1177/23779608231185921. View

Bretschneider M, Klasek J, Karbanova M, Timpel P, Herrmann S, Schwarz P . Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study. Nutrients. 2022; 14(9). PMC: 9100754. DOI: 10.3390/nu14091810. View

10.

Sarwar N, Gao P, Kondapally Seshasai S, Gobin R, Kaptoge S, Di Angelantonio E . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. PMC: 2904878. DOI: 10.1016/S0140-6736(10)60484-9. View

11.

Zimmermann G, Venkatesan A, Rawlings K, Scahill M . Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study. JMIR Diabetes. 2021; 6(2):e28033. PMC: 8209528. DOI: 10.2196/28033. View

12.

Schram M, Baan C, Pouwer F . Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009; 5(2):112-9. PMC: 2764861. DOI: 10.2174/157339909788166828. View

13.

Lee S, Park S, Park Y, Kim K, Choi H, Oh S . Effects of Short-term Mobile Application Use on Weight Reduction for Patients with Type 2 Diabetes. J Obes Metab Syndr. 2021; 30(4):345-353. PMC: 8735826. DOI: 10.7570/jomes21047. View

14.

Wang Y, Li M, Zhao X, Pan X, Lu M, Lu J . Effects of continuous care for patients with type 2 diabetes using mobile health application: A randomised controlled trial. Int J Health Plann Manage. 2019; 34(3):1025-1035. DOI: 10.1002/hpm.2872. View

15.

Lee D, Park J, Choi D, Ahn H, Park S, Park C . The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: A randomized, controlled, open-label study. Sci Rep. 2018; 8(1):3642. PMC: 5827660. DOI: 10.1038/s41598-018-22034-0. View

16.

McKenzie A, Hallberg S, Creighton B, Volk B, Link T, Abner M . A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes. JMIR Diabetes. 2018; 2(1):e5. PMC: 6238887. DOI: 10.2196/diabetes.6981. View

17.

Lim S, Ong K, Johal J, Han C, Yap Q, Chan Y . Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2021; 4(6):e2112417. PMC: 8176331. DOI: 10.1001/jamanetworkopen.2021.12417. View

18.

Dugas M, Wang W, Crowley K, Iyer A, Peeples M, Shomali M . Engagement and Outcomes Associated with Contextual Annotation Features of a Digital Health Solution. J Diabetes Sci Technol. 2020; 16(4):804-811. PMC: 9264428. DOI: 10.1177/1932296820976409. View

19.

Hemkens L . [Benefit assessment of digital health applications-challenges and opportunities]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021; 64(10):1269-1277. PMC: 8441956. DOI: 10.1007/s00103-021-03413-x. View

20.

Krishnakumar A, Verma R, Chawla R, Sosale A, Saboo B, Joshi S . Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data. J Med Internet Res. 2021; 23(3):e17908. PMC: 8074838. DOI: 10.2196/17908. View